Cargando…
Angiotensin II type 2 receptor antagonist reduces bleomycin-induced pulmonary fibrosis in mice
BACKGROUND: The role of angiotensin II type 2 receptor (AT2) in pulmonary fibrosis is unknown. To evaluate the influence of angiotensin II type 1 receptor (AT1) and AT2 antagonists in a mouse model of bleomycin (BLM)-induced pulmonary fibrosis. METHODS: We examined effects of the AT1 antagonist (AT1...
Autores principales: | Waseda, Yuko, Yasui, Masahide, Nishizawa, Yoriko, Inuzuka, Kanako, Takato, Hazuki, Ichikawa, Yukari, Tagami, Atsuro, Fujimura, Masaki, Nakao, Shinji |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409315/ https://www.ncbi.nlm.nih.gov/pubmed/18500976 http://dx.doi.org/10.1186/1465-9921-9-43 |
Ejemplares similares
-
Fractional analysis of bronchoalveolar lavage in systemic sclerosis-associated interstitial lung disease
por: Kase, Kazumasa, et al.
Publicado: (2021) -
Surfactant protein D: a useful marker for differentiation of drug-induced pneumonia and bacterial pneumonia
por: Waseda, Yuko, et al.
Publicado: (2021) -
Patients with End-stage Interstitial Lung Disease may have More Problems with Dyspnea than End-stage Lung Cancer Patients
por: Matsunuma, Ryo, et al.
Publicado: (2016) -
Immune Mechanisms of Pulmonary Fibrosis with Bleomycin
por: Ishida, Yuko, et al.
Publicado: (2023) -
Comparison of cough reflex sensitivity after an inhaled antigen challenge between actively and passively sensitized guinea pigs
por: Hara, Johsuke, et al.
Publicado: (2005)